H11.0
Pterygium of eye
Clinical Classification Guidelines
Excludes Type 1
- pseudopterygium (H11.81-)
Medical Intelligence & Overview
Pterygium of the eye is a common, non-cancerous growth that develops on the conjunctiva, the clear tissue covering the white part of the eye. Characterized by a wing-shaped fibrovascular tissue extension, it often progresses slowly over time. While usually benign, pterygium can affect vision if it enlarges and distorts the cornea. This condition frequently occurs in people exposed to prolonged sunlight, wind, or dust. Recognizing the signs and understanding potential causes can help in managing and preventing its progression.
Causes & Symptoms
Clinical Causes: Extended exposure to ultraviolet (UV) sunlight Chronic exposure to wind, dust, or environmental irritants Living in dry or dusty climates Genetic predisposition Age-related tissue changes, especially in middle-aged and elderly individuals
Key Symptoms: A visible growth on the sclera, usually on the inner corner of the eye Redness and inflammation in the affected area A sensation of grittiness, dryness, or irritation Feeling of a foreign body in the eye Blurring of vision if the growth encroaches onto the cornea Cosmetic concerns due to the appearance of the growth
Diagnostic & Treatment
Diagnosis Path: Diagnosis of pterygium typically involves a comprehensive eye examination. An eye care professional will carefully inspect the eye's surface using a slit-lamp microscope to assess the size, shape, and extent of the growth. They may also evaluate the degree of corneal involvement and examine for signs of inflammation or other related eye conditions. In some cases, additional imaging tests may be used to confirm the diagnosis or evaluate the impact on the cornea.
Treatment Protocols: Treatment options depend on the size and symptoms caused by the pterygium. Small, asymptomatic growths may be monitored regularly without immediate intervention. When the lesion causes discomfort, cosmetic concern, or affects vision, treatment strategies include: - **Medical Management:** Use of lubricating eye drops or ointments to relieve irritation; anti-inflammatory medications for inflammation. - **Surgical Removal:** For larger or visually significant pterygia, surgical excision may be recommended. The procedure aims to remove the growth and restore the eye’s appearance and function. Postoperative care might involve eye drops to prevent scarring or recurrence, along with protective measures to shield the eye from sunlight and environmental irritants. Recurrence is possible, and follow-up with an eye specialist is essential for managing long-term health.
Clinical Advice & FAQs
Billing Guidance
Is H11.0 a billable ICD-10 code?
Yes, H11.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.0?
Clinical documentation must specify the nature of Pterygium of eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
